![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 14/135 | (2006.01) |
(11) | Number of the document | 2707385 |
(13) | Kind of document | T |
(96) | European patent application number | 12722057.2 |
Date of filing the European patent application | 2012-05-14 | |
(97) | Date of publication of the European application | 2014-03-19 |
(45) | Date of publication and mention of the grant of the patent | 2017-09-20 |
(46) | Date of publication of the claims translation | 2017-12-11 |
(86) | Number | PCT/US2012/037773 |
Date | 2012-05-14 |
(87) | Number | WO 2012/158613 |
Date | 2012-11-22 |
(30) | Number | Date | Country code |
201161486005 P | 2011-05-13 | US |
(72) |
SWANSON, Kurt, US
CARFI, Andrea, US
|
(73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Iš anksto sulieti RSV F antigenai |
PRE-FUSION RSV F ANTIGENS |
Payment date | Validity (years) | Amount | |
2025-04-23 | 14 | 289.00 EUR |
2026-05-14 |